Another important pathway is associated with activating mutations in the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene occurring in approximately 30–40% of patients with cancer (52). Here, PIK3CA is linked to cancer.